AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug
Five ways coronavirus is deepening global inequality
I’m all about that yield, ’bout that yield
UK Asks More 'High-Risk' & 'Minority' Patients To Sign Up For COVID-19 Vaccine Trials
Poseida Sinks 35% On Prostate Cancer Trial Halt Following Patient Death
Beijing Touts Major COVID Vaccine Milestone As China Plays 'Catch-Up' With Russia
Why The 2020 Gold Rush Is Not Over
Digital disrupters deliver superior returns for our Small Companies Fund
S&P 500 (INDEXSP: .INX) continues to hover close to record
Tencent Music Strikes Deal With Thailand’s GMM; Analyst Upgrades To Buy
CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab
Futures Rise To All Time Highs After Chinese Liquidity Injection
The ethical case for allowing medical trials that deliberately infect humans with COVID-19
United Therapeutics Scores FDA Nod For New Tyvaso Review
Sanofi Inks Deal To Buy Principia Pharma For $3.68 Billion
Novavax Launches Covid-19 Vaccine Efficacy Trial In South Africa
Truist Raises Yelp’s PT On 'Balance Sheet Strength'
OncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead
EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 vaccine
Masimo Gets FDA Clearance For Tracking Tool In Ventilated Adult Patients
New COVID-19 Cases Hit 5-Month High In South Korea, France Smashes Post-Lockdown Record: Live Updates
AstraZeneca Clinches First Supply Deal With EU For Covid-19 Vaccine
Goldman Sachs: These 3 Stocks Can Deliver Big Returns for Investors
Weekly Market Review: Making a Run at Record Highs
Baxter Gets FDA Emergency Use Nod For Regiocit During Covid-19 Pandemic
Trump Administration picks McKesson for coronavirus vaccine distribution
Covid-19 vaccine makers must hit U.S. timing goals for full payments
Novavax Pops 7% On South Korea Deal For Global Covid-19 Vaccine Supply
Once We Have An Approved COVID-19 Vaccine, Then What?
Test = vaccine